L-148-2017

Agreement ID
L-148-2017
Lead IC
NCI
Exclusivity
Exclusive
External Party
Chimeron Bio Corporation
Fiscal Year
2021
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-4160     Virus-Like Particles That Can Deliver Proteins and RNA
TAB-4013     Cancer Immunotherapy Using Virus-like Particles